Hace casi una década, la empresa de servicios tecnológicos de salud IMS Health seleccionó 21 países que describió como “farmaemergentes” – países en desarrollo con industrias farmacéuticas con importancia creciente, entre los cuales se encontraba México.
Director, Fundación IDEA
Giulia Salieri is Director at Fundación IDEA where she has worked since 2010. Her research focuses mainly on education and innovation. She is also a partner of C230 Consultores, Fundación IDEA’s public policy consulting arm.
Previously, she worked as consultant for McKinsey and Company.
She has a MBA and a MA in Education from Stanford University, as well as a MS in Financial Economics from the Bocconi University (Italy).
Mexico has the choice to remain as a low-value manufacturer of medicines, or develop as an innovator in its own right.